Award
Johns Hopkins University 1R56AI179012-01A1
Pro-apoptotic Drugs as Host-Directed Treatments for Pulmonary Tuberculosis
Recipient
Johns Hopkins University
Award Amount
$817,941.00
Ceiling
$817,941.00
Awarded
July 31, 2024
Identifier
1R56AI179012-01A1
Award for research on pro-apoptotic drugs as host-directed treatments for pulmonary tuberculosis, funded by NIAID, led by Johns Hopkins University.
Description
The project aims to develop short, efficacious TB treatment regimens using pro-apoptotic host-directed therapies. It involves advanced imaging biomarkers and immunophenotyping. The funding is from the National Institute of Allergy and Infectious Diseases (NIAID).